REQUEST A DEMO
Total
USD $0.00
Search more companies

Mayinglong Pharmaceutical Group Co.,Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Mayinglong Pharmaceutical Group Co.,Ltd Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

The company is old Chinese brand company recognized by the Ministry of Domestic Trade originally founded in AD 1582. After 400 years of sustained and healthy development, the company has become a multi-functional international pharmaceutical group involving in drug manufacturing, drug development, drug wholesale and retail, hospital chains and other fields of specializations. Company products include Ma Yinglong Musk Hemorrhoids Ointment, musk hemorrhoids suppository, Longzhu ointment and other more than 20 varieties of medicines and drugs. It has about 300 kinds of products certified by national medical code. Company production facilities and production capacity are among the leading domestic manufacturers. According to Food and Drug Administration statistics, company’s domestic hemorrhoids pharmaceutical retail market share has reached 40% and is now the first brand in hemorrhoid treatment field.

Headquarters
No. 100, Zhoujiawan, Wuchang South Lake, Wuhan City, Hubei Province
Wuhan; Hubei; Postal Code: 430064

Contact Details: Purchase the Mayinglong Pharmaceutical Group Co.,Ltd report to view the information.

Website: http://www.mayinglong.cn

Basic Information
Total Employees:
Purchase the Mayinglong Pharmaceutical Group Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the Mayinglong Pharmaceutical Group Co.,Ltd report to view the information.
Registered Capital:
Purchase the Mayinglong Pharmaceutical Group Co.,Ltd report to view the information.
Financial Auditors:
Purchase the Mayinglong Pharmaceutical Group Co.,Ltd report to view the information.
Incorporation Date:
May 09, 1994
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
29.27%
Purchase this report to view the information.
5.21%
Purchase this report to view the information.
3.18%
Purchase this report to view the information.
1.7%
Purchase this report to view the information.
1.35%
Subsidiaries
Ma Yinglong Institute of Anorectal Diagnosis and Treatment Technology
100%
Nanchang Zhikang Management Consulting Co., Ltd.
100%
Wuhan Guangweikang Medical Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Mayinglong Pharmaceutical Group Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
14.13%
Total operating revenue
10.51%
Operating profit (EBIT)
12.13%
Net Profit (Loss) for the Period
9.7%
Total assets
2.28%
Total equity
7.44%
Operating Profit Margin (ROS)
-0.37%
Net Profit Margin
-0.68%
Return on Equity (ROE)
0.23%
Debt to Equity Ratio
-10.55%
Quick Ratio
-2.39%
Cash Ratio
-0.75%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?